Research into sodium-glucose cotransporter 2 inhibitors (SGLT2Is) suggests they might have potential anti-cancer effects due to their ability to block glucose uptake, which is crucial for cancer cell survival [38]. The gene discussed is SLC5A2; the disease is cancer.